Tegaderm vs. EyeGard for Eye Protection
A Randomized Control Trial of Tegaderm vs. EyeGard for Eye Protection During General Anesthesia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18
- Surgeries scheduled for anesthesia of any duration
Exclusion Criteria:
- Any patient that does not consent
- Any patient who has:
- Pre-existing eyelid erythema or other eyelid trauma
- Eyelid piercings
- Any surgery on the head, brain, neck, teeth, mouth, eyes or face
- Surgery in the prone position
- Patients <18 years old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: TegadermTM on R eye, EyeGard® on L eye
Patients will get TegadermTM on Right eye, EyeGard® on Left eye
|
TegadermTM and EyeGard® will be placed over patients' eyes during surgery with general anesthesia.
|
|
Experimental: TegadermTM on L eye, EyeGard® on R eye
Patients will get TegadermTM on Left eye, EyeGard® on Right eye
|
TegadermTM and EyeGard® will be placed over patients' eyes during surgery with general anesthesia.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Participants With Eyelid Erythema
Time Frame: Standardized photos will be taken within 5 minutes of removing tape after surgery (surgery of any duration)
|
The amount of erythema caused upon removal of the tape is the primary outcome of interest. Investigators will use the following 0-3 tape-associated skin index grading scale to grade eyelid erythema: 0- no erythema
|
Standardized photos will be taken within 5 minutes of removing tape after surgery (surgery of any duration)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction
Time Frame: post-operation
|
Patient Satisfaction will be based on one question and graded on a Likert Scale from 1-5.
A score of 5 is considered better (higher satisfaction), while a 1 is considered lower.
There are no subscales.
|
post-operation
|
|
Rate of Corneal Abrasions
Time Frame: post-operation
|
Corneal abrasion is assessed in the recovery room
|
post-operation
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Dan Drzymalski, MD, Tufts Medical Center Dept. of Anesthesia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 12884
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.